Planmeca Ultra Low Dose™ technology scientifically proven in several studies
Planmeca has earned a reputation as the leader in low dose CBCT imaging. The Planmeca Ultra Low Dose™ protocol has been studied in several studies, one of which concluded that the technology reduces patient doses by up to 77% with no statistical reduction in image quality between the standard and ultra low dose protocols. A recently published sixth clinical study on Planmeca Ultra Low Dose confirmed the effectivess and quality of the technology once again.
The Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology journal recently published a study that concluded that the